Repository logoRepository logo
GRO
  • GRO.data
  • GRO.plan
Help
  • English
  • Deutsch
Log In
New user? Click here to register.Have you forgotten your password?
Publications
Researcher
Organizations
Other
  • Journals
  • Series
  • Events
  • Projects
  • Working Groups

Browsing by Author "Debus, J."

Filter results by typing the first few letters
Now showing 1 - 20 of 62
  • Results Per Page
  • Sort Options
  • Some of the metrics are blocked by your 
    consent settings
    A dosimetric comparison: Intensity Modulated Proton Therapy (IMPT), Volumetric Modulated Arc Therapy (VMAT) and Three-Dimensional Conformal Radiotherapy (3D-CRT) for anaplastic astrocytoma and glioblastoma
    (2016)
    Adeberg, Sebastian
    ;
    Harrabi, Semi
    ;
    Bougatf, Nina
    ;
    Tonndorf-Martini, Eric
    ;
    Bernhardt, Denise
    ;
    Rieber, J.
    ;
    Koerber, Stefan
    ;
    Mohr, A.
    ;
    Haberer, Thomas
    ;
    Herfarth, K.
    ;
    Debus, J.
    ;
    Rieken, Stefan  
  • Some of the metrics are blocked by your 
    consent settings
    A Transcriptional Fingerprint of Carbon Ion Radiotherapy in Patients with Recurrent Glioma Utilizing Peripheral Blood as a Sentinel Organ
    (2019)
    Waltenberger, M.
    ;
    Knoll, M.
    ;
    Schlegel, J.
    ;
    Wirkner, U.
    ;
    Schwager, C.
    ;
    Bernhardt, D.
    ;
    Adeberg, S.
    ;
    Rieken, S.  
    ;
    Combs, S. E.
    ;
    Herold-Mende, C.
    ;
    Debus, J.
    ;
    Abdollahi, A.
  • Some of the metrics are blocked by your 
    consent settings
    Alkylans after alkylans: therapy results after the use of ACNU in progressive glioblastoma after primary combined radiochemotherapy as well as adjuvant chemotherapy with temozolomide
    (2009)
    Mohr, A.
    ;
    Rieken, Stefan  
    ;
    Welzel, Thomas
    ;
    Debus, J.
    ;
    Combs, Stephanie
  • Some of the metrics are blocked by your 
    consent settings
    An intraindividual comparison of target volume definition for radiation therapy based on contrast-enhanced MRI, -O-(2-[18F]-fluoroethyl)-L-tyrosine (FET)- and [68Ga]-DOTA-D Phe 1-3Tyr3-Octreotide (DOTATOC)-PET in 21 patients with meningiomas - final results
    (2013)
    Dittmar, J.
    ;
    Giesel, Frederik
    ;
    Kratochwill, K.
    ;
    Christmann, A.
    ;
    Welzel, Thomas
    ;
    Habermehl, Daniel
    ;
    Rieken, Stefan  
    ;
    Haberkorn, Uwe
    ;
    Debus, J.
    ;
    Combs, Stephanie
  • Some of the metrics are blocked by your 
    consent settings
    Carbon Ion Irradiation With Or Without The Addition Of Cilengitide Is An Effective Inhibitor Of Integrine-Mediated Tumor Cell Migration
    (2010)
    Rieken, Stefan  
    ;
    Habermehl, Daniel
    ;
    Wurth, L.
    ;
    Mohr, A.
    ;
    Lindel, K.
    ;
    Weber, Klaus
    ;
    Haberer, Thomas
    ;
    Debus, J.
    ;
    Combs, Stephanie
  • Some of the metrics are blocked by your 
    consent settings
    Combination of photon and carbon ion irradiation with targeted therapy substances in hepatocellular carcinoma cell lines
    (2014)
    Dehne, S.
    ;
    Fritz, C.
    ;
    Baris, D.
    ;
    Orschiedt, L.
    ;
    Rieken, Stefan  
    ;
    Dittmar, J.
    ;
    Brons, S.
    ;
    Haberer, Thomas
    ;
    Debus, J.
    ;
    Weber, Klaus
    ;
    Combs, Stephanie
    ;
    Habermehl, Daniel
  • Some of the metrics are blocked by your 
    consent settings
    Comparison of target volume definition for radiation therapy based on contrast-enhanced MRI, O-(2-(18F)-fluoroethyl)-L-tyrosine (FET)- and (68 Ga)-DOTA-D Phe 1-3Tyr3-Octreotide (DOTATOC)-PET in patients with meningiomas
    (2012)
    Dittmar, J.
    ;
    Giesel, Frederik
    ;
    Kratochwill, K.
    ;
    Christmann, A.
    ;
    Welzel, Thomas
    ;
    Habermehl, Daniel
    ;
    Rieken, Stefan  
    ;
    Haberkorn, Uwe
    ;
    Debus, J.
    ;
    Combs, Stephanie
  • Some of the metrics are blocked by your 
    consent settings
    Correlation of magnesium homeostasis under combined radiation chemo-immunotherapy with temozolomide with cetuximab and overall survival in patients with primary glioblastoma
    (2009)
    Rieken, Stefan  
    ;
    Mohr, A.
    ;
    Welzel, Thomas
    ;
    Milker-Zabel, S.
    ;
    Platten, M.
    ;
    Wick, Wolfgang
    ;
    Debus, J.
    ;
    Combs, Stephanie
  • Some of the metrics are blocked by your 
    consent settings
    Disrupting the mTOR pathway by mTORC1-or dual Pi3K/mTOR-inhibitors reduces cell survival and proliferation and enhances radio-sensitivity of primary meningioma cells irradiated by photons or carbon ions
    (2014)
    Dittmar, J.
    ;
    Ketter, Ralf
    ;
    Urbschat, Steffi
    ;
    Dittmar, A.
    ;
    Baris, D.
    ;
    Habermehl, Daniel
    ;
    Rieken, Stefan  
    ;
    Oertel, Joachim
    ;
    Debus, J.
    ;
    Combs, Stephanie
  • Some of the metrics are blocked by your 
    consent settings
    Effect of Carbon Ion Irradiation on Human Papillomavirus (HPV) 16 Positive Cervical Keratinocytes
    (2011)
    Lindel, K.
    ;
    Rieken, S.  
    ;
    Daffinger, S.
    ;
    Combs, S.
    ;
    Weber, K.J.
    ;
    Debus, J.
  • Some of the metrics are blocked by your 
    consent settings
    Effects of 12-week resistance training during radiotherapy in breast cancer patients
    (2017-11)
    Wiskemann, J.
    ;
    Schmidt, M. E.
    ;
    Klassen, Oliver  
    ;
    Debus, J.
    ;
    Ulrich, C. M.
    ;
    Potthoff, K.
    ;
    Steindorf, K.
    Exercise is considered to be an effective supportive treatment approach in breast cancer (BC) patients. We conducted a randomized controlled trial to assess the efficacy of a 12-week PRT during radiotherapy. Strength performance was assessed by maximal isokinetic peak torque (MIPT) in two different angular velocities (60°/s and 180°/s) and maximal voluntary isometric contraction for shoulder external and internal rotation, as well as for knee extension and flexion were assessed pre- and post-intervention in 146 patients randomized to PRT or a control group. Statistical analyses were based on analysis of covariance models for the individual changes from baseline to week 13. Intention-to-treat analyses showed significant between-group differences favoring the exercise group (EX) for MIPT in knee flexion and shoulder internal and external rotation (P < 0.05). Subgroup analyses showed borderline significant differences with regard to pretreatment history, revealing that pretreated chemotherapy patients tend to benefit more from PRT than patients without chemotherapy (P = 0.06). Strength gain at the operated arm was significantly higher than at the non-operated arm in EX. PRT was efficacious in increasing upper and lower limb strength in BC patients undergoing adjuvant radiotherapy. Patients with restrictions due to breast cancer-related surgery and pretreated with chemotherapy might benefit the most.
  • Some of the metrics are blocked by your 
    consent settings
    EP-1090: Particle therapy and IMRT for patients with esthesioneuroblastoma: a single-institution experience
    (2017)
    Liermann, J.
    ;
    Syed, M.
    ;
    Bernhardt, D.
    ;
    Bougatf, N.
    ;
    Harrabi, S.B.
    ;
    Paul, A.
    ;
    Sprave, T.
    ;
    Rieken, S.  
    ;
    Haberer, T.
    ;
    Herfarth, K.
    ;
    Debus, J.
    ;
    Hauswald, H.
    ;
    Adeberg, S.
  • Some of the metrics are blocked by your 
    consent settings
    EP-1117: Sequential Proton Boost after Standard Chemoradiation for High-Grade Glioma
    (2017)
    Adeberg, S.
    ;
    Bernhardt, D.
    ;
    Harrabi, S.
    ;
    Uhl, M.
    ;
    Paul, A.
    ;
    Bougatf, N.
    ;
    Verma, V.
    ;
    Haberer, T.
    ;
    Combs, S.
    ;
    Herfarth, K.
    ;
    Debus, J.
    ;
    Rieken, S.  
  • Some of the metrics are blocked by your 
    consent settings
    EP-1125: Concomitant temozolomide therapy improves survival outcome of patients with multifocal glioblastoma
    (2017)
    Syed, M.
    ;
    Liermann, J.
    ;
    Sprave, T.
    ;
    Verma, V.
    ;
    Rieber, J.
    ;
    Harrabi, S.B.
    ;
    Bougatf, N.
    ;
    Bernhardt, D.
    ;
    Mohr, A.
    ;
    Rieken, S.  
    ;
    Debus, J.
    ;
    Adeberg, S.
  • Some of the metrics are blocked by your 
    consent settings
    EP-1155 Rare entities in head-and-neck cancer: A single institutional experience of carbon-ion reirradiation
    (2019)
    Held, T.
    ;
    Windisch, P.
    ;
    Akbaba, S.
    ;
    Lang, K.
    ;
    Bernhardt, D.
    ;
    Plinkert, P.
    ;
    Kargus, S.
    ;
    Freier, K.
    ;
    Rieken, S.  
    ;
    Herfarth, K.
    ;
    Debus, J.
    ;
    Adeberg, S.
  • Some of the metrics are blocked by your 
    consent settings
    EP-1207: Outcomes and prognostic factors in solitary brain metastasis from small cell lung cancer
    (2017)
    Bernhardt, D.
    ;
    Adeberg, S.
    ;
    Bozorgmehr, F.
    ;
    Kappes, J.
    ;
    Hoerner-Rieber, J.
    ;
    Koenig, L.
    ;
    Debus, J.
    ;
    Thomas, M.
    ;
    Unterberg, A.
    ;
    Herth, F.
    ;
    Heussel, C.P.
    ;
    Steins, M.
    ;
    Rieken, S.  
  • Some of the metrics are blocked by your 
    consent settings
    EP-1212: Parenchymal and functional lung changes after stereotactic body radiotherapy for early-stage NSCLC
    (2017)
    Rieber, J.
    ;
    Dern, J.
    ;
    Bernhardt, D.
    ;
    König, L.
    ;
    Adeberg, S.
    ;
    Paul, A.
    ;
    Kappes, J.
    ;
    Hoffmann, H.
    ;
    Debus, J.
    ;
    Heussel, C.P.
    ;
    Rieken, S.  
  • Some of the metrics are blocked by your 
    consent settings
    EP-1215 Fibroblast Activating Protein specific PET for advanced target volume delineation in Glioblastoma
    (2019)
    Windisch, P.
    ;
    Röhrich, M.
    ;
    Regnery, S.
    ;
    Tonndorf-Martini, E.
    ;
    Held, T.
    ;
    Lang, K.
    ;
    Bernhardt, D.
    ;
    Rieken, S.  
    ;
    Haberkorn, U.
    ;
    Debus, J.
    ;
    Adeberg, S.
  • Some of the metrics are blocked by your 
    consent settings
    EP-1219: Dosimetric Comparison of Proton RT with Standard of Care Photon RT Techniques in CNS Tumors
    (2018)
    Adeberg, S.
    ;
    Harrabi, S.
    ;
    Bougatf, N.
    ;
    Verma, V.
    ;
    Bernhardt, D.
    ;
    Combs, S.
    ;
    Haberer, T.
    ;
    Herfarth, K.
    ;
    Debus, J.
    ;
    Rieken, S.  
  • Some of the metrics are blocked by your 
    consent settings
    EP-1331: Diabetes and metformin influence survival in glioblastoma patients
    (2015)
    Adeberg, S.
    ;
    Kehle, D.
    ;
    Mohr, A.
    ;
    Rieken, S.  
    ;
    Bostel, T.
    ;
    Koelsche, C.
    ;
    Diehl, C.
    ;
    Debus, J.
  • «
  • 1 (current)
  • 2
  • 3
  • 4
  • »

About

About Us
FAQ
ORCID
End User Agreement
Privacy policy
Cookie consent
Imprint

Contact

Team GRO.publications
support-gro.publications@uni-goettingen.de
Matrix Chat: #support_gro_publications
Feedback

Göttingen Research Online

Göttingen Research Online bundles various services for Göttingen researchers:

GRO.data (research data repository)
GRO.plan (data management planning)
GRO.publications (publication data repository)
Logo Uni Göttingen
Logo Campus Göttingen
Logo SUB Göttingen
Logo eResearch Alliance

Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution 4.0 International license.